piperaquine is an approved drug (EMA (2011) in combination with artenimol)
Compound class:
Synthetic organic
Comment: Piperaquine is a 4-aminoquinoline antimalarial compound.
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
No information available. |
Summary of Clinical Use ![]() |
Piperaquine is approved by the EMA for use in the treatment of malaria, only as part of an ACT with artenimol (trade name Eurartesim®). The FDA granted Orphan Drug designation for Eurartesim® in 2007 for the treatment of uncomplicated malaria (link to FDA Orphan Drug Approval record here). |
External links ![]() |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) European Medicines Agency (EMA) |